Clinical Trial Update: A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib [Phase 2]

View source ↗

Summary

A Phase II trial evaluating nivolumab, bevacizumab, and rucaparib in peritoneal cancer, ovarian cancer, and fallopian tube cancer; results have been posted as o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• OPDIVO (nivolumab)
• RUBRACA (RUCAPARIB)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Peritoneal Cancer, Ovarian Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-04-01